Neuropathology is essential to identify the true causes of brain disease. Although biomarkers are increasingly valuable as harbingers of disease in presymptomatic stages, there remains a need to validate CSF and neuroimaging biomarkers. In the older brain, more than one disease often is at work and at present only a detailed neuropathologic examination can determine the presence of coexisting diseases which may contribute in complex ways to the progression to dementia. Thus, the Neuropathology Core is essential for the ADRC to achieve its stated goals. Specifically, The Neuropathology Core has the following aims:
Aim 1 : To make neuropathologic diagnoses on all new brain accessions from ADRC research participants using standard diagnostic criteria.
Aim 2 : To perform brain autopsies and to collect, store, and distribute formalin-fixed, paraffin-embedded, and frozen brain tissue samples to support ADRC projects and investigators and outside collaborations that enhance ADRC research goals.
Aim 3 : To develop and maintain a computerized neuropathology database (CaTissue) in concert with the Data Management and Biostatistics Core (Core C) and the Clinical Core (Core B). Another interaction of the Neuropathology Core with the Clinical Core is to work closely with the Clinical Core autopsy coordinator, who is instrumental in arranging autopsy permission and in making arrangements for the body once death has occurred. This includes transporting the body to WUSM for autopsy.
Aim 4 : To support Project 2 (Aim 3), Core D will provide clinically and neuropathologically well-characterized cases of AD with and without Lewy bodies to determine how A and ?-synuclein compete for clearance pathways.
Aim 5 : To support Project 1 (Aim 2C) Core D will quantify the molecular pathology (tauopathy and -amyloidosis) in those participants who have undergone 18F-T807tau and 18F-florbetapir amyloid imaging who have come to autopsy in order to correlate PET amyloid and tau data with lesion number and density in histological sections of brain-matched areas.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005681-36
Application #
9697255
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
2021-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
36
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Strain, Jeremy F; Smith, Robert X; Beaumont, Helen et al. (2018) Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions. Neurology 91:e313-e318
Roe, Catherine M; Babulal, Ganesh M; Stout, Sarah H et al. (2018) Using the A/T/N Framework to Examine Driving in Preclinical AD. Geriatrics (Basel) 3:
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Suárez-Calvet, Marc; Capell, Anja; Araque Caballero, Miguel Ángel et al. (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med 10:
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Ogren, Jennifer A; Tripathi, Raghav; Macey, Paul M et al. (2018) Regional cortical thickness changes accompanying generalized tonic-clonic seizures. Neuroimage Clin 20:205-215
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Aschenbrenner, Andrew J; Gordon, Brian A; Benzinger, Tammie L S et al. (2018) Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology 91:e859-e866
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872

Showing the most recent 10 out of 952 publications